Posts by rw-admin
Grupo Financiero Galicia $636 million secondary offering
Davis Polk represented the representatives of the several underwriters in the $636 million SEC-registered secondary offering of 11,721,449 American depositary shares representing 117,214,490 Class B ordinary shares of Grupo Financiero Galicia by HSBC Bank plc.
Read MoreOcado Group £100 million high-yield bond tap and £80 million convert repurchaseJune 14, 2025Experience
Davis Polk represented Ocado Group and certain of its subsidiaries, as guarantors, in the repurchase of £80 million in aggregate principal amount of its 0.875% senior unsecured convertible bonds due 2025 and issuance via a private placement of £100 million in aggregate principal amount of 11% senior unsecured notes due 2030.
Read MoreIREN $550 million convertible notes offering
Davis Polk represented IREN Limited in its Rule 144A offering of $550 million aggregate principal amount of its 3.50% convertible senior notes due 2029, which included $50 million aggregate principal amount of notes pursuant to the exercise in full of the initial purchasers’ option to purchase additional notes.
Read MoreSouthState $350 million subordinated notes offering
Davis Polk represented SouthState Corporation in its SEC-registered offering of $350 million aggregate principal amount of fixed-to-floating-rate subordinated notes due 2035.
Read MoreKarooooo $75 million secondary offering
Davis Polk represented Karooooo Ltd. and its founder and CEO, Isaias (Zak) Jose Calisto, as the selling shareholder, in the $75 million SEC-registered secondary offering of 1,500,000 ordinary shares of Karooooo by the selling shareholder.
Read MoreGibson Dunn Continues Expansion of Market-Leading Investment Funds Team With the Arrival of Partner Carolyn Abram in Dubai
Gibson Dunn is adding Carolyn (Caro) Abram to the firm’s Dubai office as a partner in its Investment Funds Practice Group.
Read MoreGoodwin Advises Glean in $150M Series F at $7.2B Valuation to Accelerate Enterprise AI Agent Innovation Globally
Goodwin Procter represented Glean in the $150 million in Series F financing raising, bringing its valuation to $7.2 billion.
Read MoreGoodwin Guides Deep Apple Therapeutics in Collaboration with Novo Nordisk to Discover and Develop Oral Therapeutics for Cardiometabolic Diseases for up to $812 Million
Goodwin Procter acted for Deep Apple Therapeutics in a research collaboration and exclusive worldwide license agreement with Novo Nordisk to discover, develop, and commercialize oral small molecule therapeutics directed at a novel non-incretin GPCR target for cardiometabolic diseases.
Read MoreRivian Completes Refinancing
Simpson Thacher & Bartlett acted for the initial purchasers, led by J.P. Morgan Securities LLC, in the Rule 144A/Regulation S offering by Rivian Holdings, LLC, Rivian, LLC and Rivian Automotive, LLC of $1.25 billion aggregate principal amount of 10.000% Senior Secured Green Notes due 2031.
Read MoreFord Foundation Invests in Nine Dean
Simpson Thacher acted for the Ford Foundation in its investment in Nine Dean that will allow it to officially launch with an experienced team with the goal of acquiring middle-market businesses with the goal of stewarding them toward operational success.
Read More